The HealthInvestor Asia Awards celebrate excellence and recognise innovation in the healthcare sector. In each of the categories an independent panel of high profile judges will be looking for organisations and individuals that have made an outstanding contribution to healthcare in 2018.
To enter your business or team, or to nominate someone else, simply complete the entry form below and explain in no more than 2,000 words why they should win. The closing date for entries will be Friday 18 January 2019.
The judges will only consider applications that include the following points.
All points need to be covered in the 2,000 word limit.
Submissions must include a fully completed entry form (below) and be no more than 2,000 words.
The judging panel reserves the right to move entries from one category to another if they feel it is more appropriate. Please ensure that all information in submissions is accurate at the time of entry. HealthInvestor Asia will not be held responsible for the publication of any information contained on the entry forms which is inaccurate.
The awards will follow a nomination process where companies will be nominated by the public or self-submission in each relevant category. Please provide a comprehensive reason for your nomination.
Nominations must be completed by the closing date of 18 January 2018
Judging the HealthInvestor Asia Awards is an honour. Judges are chosen for their reputation and independence. Typical profiles of judge include association leaders, think tank leaders, analysts and consultants, independent investors, and (often retired) industry leaders and ambassadors. HealthInvestor Asia diligently to anticipate any conflicts of interest, which judges are expected to declare when categories are allocated.
Once applications are closed, the HealthInvestor Asia editorial team will vet entries and remove any that have not met the basic stipulated requirements.
HealthInvestor Asia Awards 2019
14 May 2019
HealthInvestor Asia (HIA) is the definitive source of financial intelligence for Apac’s growing healthcare markets.
HIA’s dedicated coverage of corporate and capital market activity in the healthcare sector provides independent and authoritative insight for investors, lenders, advisors and healthcare firms operating across the region.
By focusing specifically on the health sector, HIA provides forensic analysis of this vital and growing market.
HIA’s market-leading editorial coverage enables readers to grasp the complexities of the region and follow the flow of investment across health systems in Asia. Its market commentary and analysis is an invaluable tool in identifying trends and opportunities and its focused reporting allows readers to keep up to date with this fast-moving and exciting sector.
Paul Routley | +44(0)207 104 2006
Ivan Ujvari | +44(0)207 104 2058